Omada Health Analyst Price Targets

Omada Health Inc

OMDANASDAQ

$23.69

-0.58-2.39%

In chiusura: Aug 28, 5:00 PM EST

$23.82

0.130.56%

Post-mercato: 6:38 PM EST

Wall Street analyst price targets and consensus rating for Omada Health (OMDA).

Price Target Range — 5 Quarters

Analyst Consensus — 11 Analysts

1S.Buy

9Buy

1Hold

Consensus RatingOverweight# Analysts11Avg. Consensus PT$26Upside to Avg. PT+8.3%

Rating Trend — Last 9 Months

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 14, 2026	JP Morgan	Lisa Gill	PT Raise	Overweight	$26→$30
Aug 14, 2026	Citizens	Constantine Davides	PT Raise	Market Outperform	$27→$32
Aug 12, 2026	Baird	Vikram Kesavabhotla	PT Raise	Neutral	$15→$25
Aug 10, 2026	BTIG	David Larsen	PT Raise	Buy	$30→$35
Aug 3, 2026	Barclays	Saket Kalia	PT Raise	Overweight	$20→$25
Jul 21, 2026	Canaccord Genuity	Richard Close	PT Raise	Buy	$24→$28
Jul 20, 2026	Citizens	Constantine Davides	PT Raise	Market Outperform	$21→$27
Jul 17, 2026	BTIG	David Larsen	Initiate	Buy	$30
Jun 22, 2026	Morgan Stanley	Craig Hettenbach	Maintained	Overweight	$30
May 8, 2026	Barclays	Saket Kalia	PT Raise	Overweight	$18→$20
May 8, 2026	Citizens	Constantine Davides	PT Raise	Market Outperform	$18→$21
May 8, 2026	Evercore ISI Group	Elizabeth Anderson	PT Raise	Outperform	$15→$20
May 8, 2026	Wells Fargo	Stan Berenshteyn	PT Raise	Equal-Weight	$17→$18
May 8, 2026	Needham	Ryan MacDonald	Maintained	Buy	$28
Apr 14, 2026	Citizens	Constantine Davides	Initiate	Market Outperform	$18
Apr 9, 2026	Goldman Sachs	David Roman	PT Cut	Buy	$26→$23
Apr 8, 2026	Evercore ISI Group	Elizabeth Anderson	PT Cut	Outperform	$20→$15
Mar 12, 2026	JP Morgan	Destiny Jackson	PT Cut	Overweight	$32→$26
Mar 6, 2026	Canaccord Genuity	Richard Close	PT Cut	Buy	$28→$22
Mar 6, 2026	BMO Capital	Sean Dodge	PT Cut	Outperform	$27→$18